Identification and evaluation of antiviral activity of novel compounds targeting SARS-CoV-2 virus by enzymatic and antiviral assays, and computational analysis
The viral genome of the SARS-CoV-2 coronavirus, the aetiologic agent of COVID-19, encodes structural, non-structural, and accessory proteins.Most of these components undergo rapid genetic variations, though to a lesser extent the essential viral proteases.Consequently, the protease and/or deubiquitinase activities of the cysteine proteases Mpro and